Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Allergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis

Devyn Gehret

Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.

Advertisement

In This Series

View More

Advertisement